On 05.07.2018, EMA – the European Medicines Agency, issued a statement on the so-called “precautionary recall” of valsartan-containing products due to a received signal for a detected adulteration in the raw substance, namely NDMA – N-nitrosodimethylamine. The signal was submitted by the manufacturing company, namely the China-based “Zhejiang Huahai …
More »Press Conference: Progeneric Policy for Lower Drug Costs
In connection with the deepening financial instability of the healthcare sector in Bulgaria, the experts from the EKIP have found a solution to the problem of the continuous increase in the costs of medicines of the NHIF. The analysis used data from the drug group of sartans (medicinal products for the treatment of arterial hypertension) for the period 2005-2016. …
More »Reform for more accessible and cheaper medicines in Bulgaria
|Full text of the analysis| Summary and conclusions from the analysis of the sartan group: The results of this study confirm the conclusions of previous analyses, such as the World Bank's 2015 analysis, as well as good practices from EU countries, and quantify the positive effects of implementing a progeneric policy within the framework of …
More »Why are medicines disappearing from the Bulgarian market?
What is the problem? One of the main problems with drugs disappearing from the Bulgarian market is state regulation, which is expressed in the form of price controls. The Bulgarian government experimented with freezing drug prices in 2013 and 2014, which negatively affected the market and caused …
More »The problem is not parallel export of medicines, but low incomes
Author: Kaloyan Staykov In mid-August, the government published for public discussion warmed-up proposals for reform of the drug policy, with the focus on improving access to medicinal products in the country. The problem with access arises mainly for two reasons: parallel export[1] – it is envisaged to create a restrictive list of medicines whose export can be …
More »Cheaper drugs? Why not?!
As we have already understood, the budget of the National Health Insurance Fund (NHIF) grows annually and unjustifiably. On the other hand, mortality is increasing, while diseases are showing a constant trend. Theft through referrals has been a known fact for years and is easily noticeable in regional statistics. Since we have begun to dismantle the healthcare system, we must …
More »
EKIP– Expert Club for Economics and Politics A Different Opinion